Ledger.Open graph →
SEC Form D · filed February 24, 2021

Enveric Biosciences, Inc

Offering
$8.4M
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NAPLES, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Robert J. Moser · Saratoga Springs, NYExecGeorge Kegler · Naples, FLDirectorSol Mayer · Naples, FLDirectorTodd A. Wyatt · Royal Oak, MIExec · DirectorMaureen Z. Offer · Menlo Park, CADirectorDavid Johnson · Naples, FLExec · DirectorAvani Kanubaddi · Naples, FLExec · DirectorMark Lee · New York, NYDirectorJohn Van Buiten · Naples, FLExecGary A. Zdolshek · Independance, OHExecMarcus Schabacker · Naples, FLDirectorScott A. Fine · Westport, CTDirectorThomas J. Bartos · Independence, OHDirectorGarrett E. Zdolshek · Independence, OHDirectorGenevieve Gilbreath · Austin, TXExec · DirectorRonan Guilfoyle · George Town, Grand Cayman, Cayman IslandsExec · DirectorBrian Blagg · Indianapolis, INDirectorRalph N. Strayhorn, Iii · Charlotte, NCExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗